In part 5 of this Exclusive Interview, Joel Goldsmith talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about Abbott’s response to the ambulatory glucose profile recommendation by AACE.
Joel Goldsmith is the Senior Director of Digital Platforms at Abbott Diabetes Care where he and his team are focused on designing, developing, and commercializing software-based products and services.
Transcript of this video segment:
Steve Freed – The AACE recently added the ambulatory glucose profile report to its recommendation. How does Abbott plan to address this recommendation?
Joel Goldsmith –We were one of the first companies to embrace AGP as a visualization technique. It’s been part of the application software that ships with the Freestyle Libre system in the Freestyle Libre Pro system from day one. So, we recognized it as a really effective clinical decision support tool and we’re thrilled that it’s now becoming a standard visualization technique so we fully intend to implement the new standardized glucose report based on those published AACE guidelines and we’re going to do that this year.
Steve Freed — Are you presenting anything here at the ADA this year as far as any studies or any abstracts?
Joel Goldsmith –I believe there are some studies and abstracts associated with the use of AGP in helping to sort of demonstrate how that’s being utilized in clinical practice and the effectiveness as a visualization tool.
Steve Freed — You mentioned AGP but we didn’t define that yet.
Joel Goldsmith –Ambulatory Glucose Profile and maybe you can show an example of that in your website that helps really expose what that technique does. Essentially it normalizes data over a defined period of time. Could be as little as 5 days, up to maybe 90 days and shows that the glucose variability.